DigitalHealth InvestorTalk Show

Longevity care is making advances and growing more popular among consumers. What is a framework to start extending your healthspan?Longevity isn’t just about adding years to life, it’s about adding life to those years. What steps can you take today to extend your healthspan and enhance your quality of life? What framework can help you identify major risks and set yourself up for long-term vitality?In this show we'll cover:- A practical framework for extending your healthspan- The major health risks and how to prevent problems starting early- The latest advances in longevity scienceAnd we'll answer your questions.Dr. Soheil Saadat is the founder and CEO of GenieMD, a San Francisco Bay Area–based telemedicine and digital health company that has treated millions of patients worldwide. GenieMD focuses on virtual care that promotes vitality and longevity, AI-driven chronic disease management, and advanced healthcare communication technologies. Elora Health, a part of GenieMD, is dedicated to longevity, prevention, and healthspan optimization.Steven Wardell is the Managing Partner of Wardell Advisors, a consulting firm focused on growth, fundraising, and strategic alternatives for digital health companies. He is the host of DigitalHealth InvestorTalk and the author of The Future of Digital Health. Follow for digital health insights at X.com/StevenWardell.

Payers and Providers are looking for greater efficiency using GenAI. But what happens when they unleash the latest AI tools on each other?There are many opportunities in the healthcare system for GenAI to make contributions in billing, coding, medical records, and administrative. But what happens when providers use the latest in AI to supercharge billing to payers and payers arm up to manage and mitigate and deny?In this show we'll cover:- The problems of inefficienty in administrative processes in healthcare- Opportunities for GenAI at payers and providers in administrative and clinical- The new arms race over billing between payers and providersAnd we'll answer your questions.Fawad Butt is the co-founder and CEO of Penguin Ai, a GenAI product company that is optimizing the healthcare back office for payers and providers. He is the former Chief Data Officer of Kaiser Permanente. Follow him on LinkedIn.Steven Wardell is the Managing Partner of Wardell Advisors, a consulting firm focused on growth, fundraising, and strategic alternatives for digital health companies. He is the host of DigitalHealth InvestorTalk and the author of The Future of Digital Health. Follow for digital health insights at X.com/StevenWardell.

You need more than GenAI. Entrepreneurs need to keep the focus on solving the buyers' biggest pain points.GenAI is the hottest buzzword in healthcare, and it seems almost necessary to be a "GenAI Native" company in order to win VC funding today.As founders debate whether to have a proprietary LLM and where how to have a moat in the age of GenAI, it's important not to lose sight of the most basic ingredient for an innovative product: to solve a major pain point for the buyer using whichever technology approach you use.In this show we'll cover:- While GenAI is all the rage, you need more than just AI- How to know you're solving the buyer's biggest problems and how to build a moat- Are services companies dead? Where do medical devices and disgnostics fit in?- What to do when clinical buyers don't even want GenAIAnd we'll answer your questions.Lisa Suennen is a partner at AHA Ventures, the fund of the American Heart Association, and she's the Venture Valkyrie. Follow her at: https://www.linkedin.com/in/lisasuennen/Steven Wardell is the Managing Partner of Wardell Advisors, a consulting firm focused on growth, fundraising, and strategic alternatives for digital health companies. He is the host of DigitalHealth InvestorTalk and the author of The Future of Digital Health. Follow for digital health insights at X.com/StevenWardell.

As digital health retrenches and AI explodes, what are creative ways for entrepreneurs to raise money?Digital health fundraising is tough as business uncertainty grows and VCs retrench. But buoyed by positive regulatory shifts and new technologies, crowdfunding and competitions are emerging as a new way for innovators to win visibility, validation, and funding for their companies.In this show we'll cover:1. What's the state of the fundraising environment for young digital health companies2. How has the environment for crowdfunding and competitions evolved?3. What are some differences and benefits of crowdfundingAnd we'll answer your questions.Alex Fair is the Managing Partner of MedStartr VenturesSteven Wardell is the Managing Partner of Wardell Advisors, a consulting firm focused on growth, fundraising, and strategic alternatives for digital health companies. He is the host of DigitalHealth InvestorTalk and the author of The Future of Digital Health. Follow for digital health insights at X.com/StevenWardell.

New capabilites in the consumertech we buy is bringing to our fingertips new sensors, new data, better data, and new forms of careTherapeutic videogames for kids with ADHD, giving voice to people who have lost the ability to speak, preventing nightmares, predicting heart attacks. . .Modern consumertech has new sensors and capabilities giving us better data, analysis, prediction, diagnosis, monitoring, and therapeutic options.In this show we'll cover:The new tech in consumer devicesWhere it is working in careThe regulatory environmentCreative applications of new tech to careAnd we'll answer your questions.Maheen Adamson is a clinical professor at Stanford Neurosurgery and the CEO of Soof Solutions, a neurosolution provider that restores voice to the speechless.Steven Wardell is the Managing Director of Wardell Advisors, a digital health business development consulting firm and the author of The Future of Digital Health.

New therapies are shaking up the super-category of obssity and diabetes care but it's not enough to just take a drug

GenAI business models in healthcare look different than the digital health revolution of 2009, which was about SaaS and workflow automation.GenAI business models are about intelligently converting free data into structured fields, making decisions, and taking action, which puts them ahead of older digital health models of simple workflow automation powered by software licensing and SaaS business models. Will that be enough to create winner GenAI companies where the last generation failed?In this show we'll cover:Looking at reasons old digital health business models failedHow GenAI is different and why Gen AI companies have advantages compared to incumbents nowWhere does Agentic AI fit in?How AI regulation will shape what's possible in healthcareHow do digital health companies succeed in this challenging environment?And we'll answer your questions.Marco Smit is the head of business development at Gesund.ai, which helps AI teams become ready for the FDA. You can follow him on LinkedIn.Steven Wardell is the Managing Director of Wardell Advisors, a digital health business development consulting firm and the author of The Future of Digital Health. You can follow him at X.com/StevenWardell

Looking at the business models and trends in digital health, few have led to successful exits. We look in to what it means for the future.Electronic medical records, revenue cycle management, telehealth, digital care management, virtual clinics, clinical decision support tools, employer health benefits, clinical trial automation software, drug discovery software. There have been few successful exits in digital health. We look at why.In this show we'll cover:Specific cases like Teladoc, Livongo, 23andMe, Epic, and more.SPACs and Chinese reverse mergersThe structure of the industry and what it means for the futureAnd we'll answer your questions.Steve Rubis is Chief of Staff at Access TeleCare, a telehealth company, and he was formerly a digital health equity research analyst on Wall Street . You can follow him on LinkedIn.Steven Wardell is the Managing Director of Wardell Advisors, a digital health business development consulting firm and the author of The Future of Digital Health. You can follow him at X.com/StevenWardell

The Digital Health sector is driving into new opportunities along with technology and economic shocks. We take a look at what's working.The digital health sector is uncovering new opportunities for technology in healthcare and new business models while being roiled by technological and economic shocks. Meanwhile there is a cloud over the industry - why so few big tech winners and successful exits?In this show we'll cover:What products are working in the marketplace?What new technologies, products, and business models are appearing?What do the economic shocks mean for young companies?When will we see more successful exits?And we'll answer your questions.Amrit Panjabi is the Digital Health analyst at CB Insights and a venture capital fellow at Alumni Ventures. You can follow him on LinkedIn.Steven Wardell is the Managing Director of Wardell Advisors, a digital health business development consulting firm and the author of The Future of Digital Health. You can follow him at X.com/StevenWardell

Alyssa Jaffee, a partner at 7wire Ventures focused on healthcare technology, and Chrissy Farr, founder of Scrub Capital and CEO of Second Opinion Media, discuss the pressing need for digital health companies to scale in an increasingly competitive landscape. They analyze the challenges posed by large healthcare incumbents and the necessity for startups to solve bigger problems to remain relevant. The conversation also touches on fundraising dynamics, the split in investor interest, and the potential for mergers and acquisitions to aid in growth.